Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Evaluation

NCT05606042 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2026-03-20

No results posted yet for this study

Summary

Prospective, single arm, post-market evaluation to evaluate the use and performance of the IM Implant in a post market setting.

Conditions

  • Pelvic Ring Fracture
  • Acetabular Fracture
  • Pelvic Fracture
  • Pelvic Fracture Acetabulum

Interventions

DEVICE

IM Implant

Patients that have had surgical interventions with one or more IM Implant as part of standard of care for a pelvic and/or acetabular fracture

Sponsors & Collaborators

  • CurvaFix, Inc.

    lead INDUSTRY

Principal Investigators

  • Jennifer Hebert · Clin-Assist, LLC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2023-03-09
Completion
2023-03-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05606042 on ClinicalTrials.gov